iRhythm Technologies, Inc. has received FDA clearance for its Zio AT device, a mobile cardiac telemetry device, after design changes. The company expects a second clearance soon, which could help it narrow the competitive gap in the market. This positive news has boosted IRTC stock by over 20%.